אודנטרון ישראל - עברית - Ministry of Health

אודנטרון

k.s.kim international (sk- pharma) ltd., israel - ondansetron as hydrochloride dihydrate - תמיסה להזרקה - ondansetron as hydrochloride dihydrate 2 mg/ml - ondansetron - ondansetron - adults: odnatron is indicated for the management of nausea and vomiting induced by cytotoxic chemotherapy and radiotherapy. odnatron is indicated for the prevention and treatment of post-operative nausea and vomiting (ponv).paediatric population: odantron is indicated for the management of chemotherapy-induced nausea and vomiting (cinv) in children aged ?6 months, and for the prevention and treatment of ponv in children aged ?2 years.

Tevadaptor - Closed drug reconstitution system ישראל - עברית - Ministry of Health

tevadaptor - closed drug reconstitution system

teva medical ltd. - migada - אחות - see attached document : us fda 510(k) k051669 approved indications for use

טבעגרסטים ישראל - עברית - Ministry of Health

טבעגרסטים

teva israel ltd - filgrastim - תמיסה להזרקה\אינפוזיה - filgrastim 0.6 mg/ml - filgrastim - filgrastim - tevagrastim is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes ) and for the reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone marrow transplantation considered to be at increased risk of prolonged severe neutropenia. the safety and efficacy of tevagrastim are similar in adults and children receiving cytotoxic chemotherapy. tevagrastim is indicated for the mobilisation of peripheral blood progenitor cells in normal donors (allogeneic pbpc). in patients children or adults with severe congenital neutropenia cyclic or idiopathic neutropenia with an absolute nuetrophil count (anc) less than or equal to 0.5 x 1000000000 /l and a history of severe or recurrent infections long term administration of tevagrastim is indicated to increase neutophil count and to red

טבעקוטן ישראל - עברית - Ministry of Health

טבעקוטן

teva israel ltd - clotrimazole; dexamethasone acetate; neomycin sulfate - קרם - clotrimazole 1 %; dexamethasone acetate 0.044 %; neomycin sulfate 0.645 % - dexamethasone - dexamethasone - tevacutan is indicated for the treatment of mycotic infections of the skin complicated by inflammation and/or secondary infection.

קרוודילול טבע    6.25 מג ישראל - עברית - Ministry of Health

קרוודילול טבע 6.25 מג

teva israel ltd - carvedilol - טבליה - carvedilol 6.25 mg - carvedilol - carvedilol - treatment of symptomatic congestive heart failure. carvedilol teva may be used as adjunct to standard therapy, but may also be used in those patients unable to tolerate an ace inhibitor, or those who are not receiving digitalis, hydralazine or nitrate therapy.

קרוודילול טבע   12.5 מג ישראל - עברית - Ministry of Health

קרוודילול טבע 12.5 מג

teva israel ltd - carvedilol - טבליה - carvedilol 12.5 mg - carvedilol - carvedilol - treatment of symptomatic congestive heart failure. carvedilol teva may be used as adjunct to standard therapy, but may also be used in those patients unable to tolerate an ace inhibitor, or those who are not receiving digitalis, hydralazine or nitrate therapy.

סיטאגליפטין טבע  100 מג   ישראל - עברית - Ministry of Health

סיטאגליפטין טבע 100 מג

teva israel ltd - sitagliptin as malate - טבליות מצופות פילם - sitagliptin as malate 100 mg - sitagliptin

סיטאגליפטין טבע  25 מג   ישראל - עברית - Ministry of Health

סיטאגליפטין טבע 25 מג

teva israel ltd - sitagliptin as malate - טבליות מצופות פילם - sitagliptin as malate 25 mg - sitagliptin

סיטאגליפטין טבע  50 מג   ישראל - עברית - Ministry of Health

סיטאגליפטין טבע 50 מג

teva israel ltd - sitagliptin as malate - טבליות מצופות פילם - sitagliptin as malate 50 mg - sitagliptin

אזיתרומיצין טבע ישראל - עברית - Ministry of Health

אזיתרומיצין טבע

teva pharmaceutical industries ltd, israel - azithromycin - אבקה להכנת תרחיף - azithromycin 200 mg / 5 ml - azithromycin - azithromycin - for infections caused by susceptible organisms :in lower respiratory tract infections including bronchitis and pneumonia, in skin and soft tissue infections, in otitis media and in upper respiratory tract infections including sinusitis and pharyngitis tonsillitis. azithromycin teva is also indicated in the treatment of uncomplicated genital infections due to chlamydia trachomatis.